Request for Covid-19 Impact Assessment of this Report
The United States Genetic Vaccine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Genetic Vaccine market, reaching US$ million by the year 2028. As for the Europe Genetic Vaccine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Genetic Vaccine players cover Merck, GSK, Sanofi, and Zoties, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Recombinant Protein Vaccine
Gene-Based Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Human
Animal
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer-Ingelheim
Indian Immunologicals
Plumbline Life Sciences
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genetic Vaccine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Genetic Vaccine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Genetic Vaccine by Country/Region, 2017, 2022 & 2028
2.2 Genetic Vaccine Segment by Type
2.2.1 Recombinant Protein Vaccine
2.2.2 Gene-Based Vaccine
2.3 Genetic Vaccine Sales by Type
2.3.1 Global Genetic Vaccine Sales Market Share by Type (2017-2022)
2.3.2 Global Genetic Vaccine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Genetic Vaccine Sale Price by Type (2017-2022)
2.4 Genetic Vaccine Segment by Application
2.4.1 Human
2.4.2 Animal
2.5 Genetic Vaccine Sales by Application
2.5.1 Global Genetic Vaccine Sale Market Share by Application (2017-2022)
2.5.2 Global Genetic Vaccine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Genetic Vaccine Sale Price by Application (2017-2022)
3 Global Genetic Vaccine by Company
3.1 Global Genetic Vaccine Breakdown Data by Company
3.1.1 Global Genetic Vaccine Annual Sales by Company (2020-2022)
3.1.2 Global Genetic Vaccine Sales Market Share by Company (2020-2022)
3.2 Global Genetic Vaccine Annual Revenue by Company (2020-2022)
3.2.1 Global Genetic Vaccine Revenue by Company (2020-2022)
3.2.2 Global Genetic Vaccine Revenue Market Share by Company (2020-2022)
3.3 Global Genetic Vaccine Sale Price by Company
3.4 Key Manufacturers Genetic Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetic Vaccine Product Location Distribution
3.4.2 Players Genetic Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Genetic Vaccine by Geographic Region
4.1 World Historic Genetic Vaccine Market Size by Geographic Region (2017-2022)
4.1.1 Global Genetic Vaccine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Genetic Vaccine Annual Revenue by Geographic Region
4.2 World Historic Genetic Vaccine Market Size by Country/Region (2017-2022)
4.2.1 Global Genetic Vaccine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Genetic Vaccine Annual Revenue by Country/Region
4.3 Americas Genetic Vaccine Sales Growth
4.4 APAC Genetic Vaccine Sales Growth
4.5 Europe Genetic Vaccine Sales Growth
4.6 Middle East & Africa Genetic Vaccine Sales Growth
5 Americas
5.1 Americas Genetic Vaccine Sales by Country
5.1.1 Americas Genetic Vaccine Sales by Country (2017-2022)
5.1.2 Americas Genetic Vaccine Revenue by Country (2017-2022)
5.2 Americas Genetic Vaccine Sales by Type
5.3 Americas Genetic Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetic Vaccine Sales by Region
6.1.1 APAC Genetic Vaccine Sales by Region (2017-2022)
6.1.2 APAC Genetic Vaccine Revenue by Region (2017-2022)
6.2 APAC Genetic Vaccine Sales by Type
6.3 APAC Genetic Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Genetic Vaccine by Country
7.1.1 Europe Genetic Vaccine Sales by Country (2017-2022)
7.1.2 Europe Genetic Vaccine Revenue by Country (2017-2022)
7.2 Europe Genetic Vaccine Sales by Type
7.3 Europe Genetic Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genetic Vaccine by Country
8.1.1 Middle East & Africa Genetic Vaccine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Genetic Vaccine Revenue by Country (2017-2022)
8.2 Middle East & Africa Genetic Vaccine Sales by Type
8.3 Middle East & Africa Genetic Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetic Vaccine
10.3 Manufacturing Process Analysis of Genetic Vaccine
10.4 Industry Chain Structure of Genetic Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetic Vaccine Distributors
11.3 Genetic Vaccine Customer
12 World Forecast Review for Genetic Vaccine by Geographic Region
12.1 Global Genetic Vaccine Market Size Forecast by Region
12.1.1 Global Genetic Vaccine Forecast by Region (2023-2028)
12.1.2 Global Genetic Vaccine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Genetic Vaccine Forecast by Type
12.7 Global Genetic Vaccine Forecast by Application
13 Key Players Analysis
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Genetic Vaccine Product Offered
13.1.3 Merck Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Genetic Vaccine Product Offered
13.2.3 GSK Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Genetic Vaccine Product Offered
13.3.3 Sanofi Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Zoties
13.4.1 Zoties Company Information
13.4.2 Zoties Genetic Vaccine Product Offered
13.4.3 Zoties Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Zoties Main Business Overview
13.4.5 Zoties Latest Developments
13.5 Elanco
13.5.1 Elanco Company Information
13.5.2 Elanco Genetic Vaccine Product Offered
13.5.3 Elanco Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Elanco Main Business Overview
13.5.5 Elanco Latest Developments
13.6 Boehringer-Ingelheim
13.6.1 Boehringer-Ingelheim Company Information
13.6.2 Boehringer-Ingelheim Genetic Vaccine Product Offered
13.6.3 Boehringer-Ingelheim Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boehringer-Ingelheim Main Business Overview
13.6.5 Boehringer-Ingelheim Latest Developments
13.7 Indian Immunologicals
13.7.1 Indian Immunologicals Company Information
13.7.2 Indian Immunologicals Genetic Vaccine Product Offered
13.7.3 Indian Immunologicals Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Indian Immunologicals Main Business Overview
13.7.5 Indian Immunologicals Latest Developments
13.8 Plumbline Life Sciences
13.8.1 Plumbline Life Sciences Company Information
13.8.2 Plumbline Life Sciences Genetic Vaccine Product Offered
13.8.3 Plumbline Life Sciences Genetic Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Plumbline Life Sciences Main Business Overview
13.8.5 Plumbline Life Sciences Latest Developments
14 Research Findings and Conclusion
Table 1. Genetic Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Genetic Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Recombinant Protein Vaccine
Table 4. Major Players of Gene-Based Vaccine
Table 5. Global Genetic Vaccine Sales by Type (2017-2022) & (K Units)
Table 6. Global Genetic Vaccine Sales Market Share by Type (2017-2022)
Table 7. Global Genetic Vaccine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Genetic Vaccine Revenue Market Share by Type (2017-2022)
Table 9. Global Genetic Vaccine Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Genetic Vaccine Sales by Application (2017-2022) & (K Units)
Table 11. Global Genetic Vaccine Sales Market Share by Application (2017-2022)
Table 12. Global Genetic Vaccine Revenue by Application (2017-2022)
Table 13. Global Genetic Vaccine Revenue Market Share by Application (2017-2022)
Table 14. Global Genetic Vaccine Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Genetic Vaccine Sales by Company (2020-2022) & (K Units)
Table 16. Global Genetic Vaccine Sales Market Share by Company (2020-2022)
Table 17. Global Genetic Vaccine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Genetic Vaccine Revenue Market Share by Company (2020-2022)
Table 19. Global Genetic Vaccine Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Genetic Vaccine Producing Area Distribution and Sales Area
Table 21. Players Genetic Vaccine Products Offered
Table 22. Genetic Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Genetic Vaccine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Genetic Vaccine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Genetic Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Genetic Vaccine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Genetic Vaccine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Genetic Vaccine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Genetic Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Genetic Vaccine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Genetic Vaccine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Genetic Vaccine Sales Market Share by Country (2017-2022)
Table 35. Americas Genetic Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Genetic Vaccine Revenue Market Share by Country (2017-2022)
Table 37. Americas Genetic Vaccine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Genetic Vaccine Sales Market Share by Type (2017-2022)
Table 39. Americas Genetic Vaccine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Genetic Vaccine Sales Market Share by Application (2017-2022)
Table 41. APAC Genetic Vaccine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Genetic Vaccine Sales Market Share by Region (2017-2022)
Table 43. APAC Genetic Vaccine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Genetic Vaccine Revenue Market Share by Region (2017-2022)
Table 45. APAC Genetic Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Genetic Vaccine Sales Market Share by Type (2017-2022)
Table 47. APAC Genetic Vaccine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Genetic Vaccine Sales Market Share by Application (2017-2022)
Table 49. Europe Genetic Vaccine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Genetic Vaccine Sales Market Share by Country (2017-2022)
Table 51. Europe Genetic Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Genetic Vaccine Revenue Market Share by Country (2017-2022)
Table 53. Europe Genetic Vaccine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Genetic Vaccine Sales Market Share by Type (2017-2022)
Table 55. Europe Genetic Vaccine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Genetic Vaccine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Genetic Vaccine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Genetic Vaccine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Genetic Vaccine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Genetic Vaccine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Genetic Vaccine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Genetic Vaccine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Genetic Vaccine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Genetic Vaccine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Genetic Vaccine
Table 66. Key Market Challenges & Risks of Genetic Vaccine
Table 67. Key Industry Trends of Genetic Vaccine
Table 68. Genetic Vaccine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Genetic Vaccine Distributors List
Table 71. Genetic Vaccine Customer List
Table 72. Global Genetic Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Genetic Vaccine Sales Market Forecast by Region
Table 74. Global Genetic Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Genetic Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Genetic Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Genetic Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Genetic Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Genetic Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Genetic Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Genetic Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Genetic Vaccine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Genetic Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Genetic Vaccine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Genetic Vaccine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Genetic Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Genetic Vaccine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Genetic Vaccine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Genetic Vaccine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Genetic Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Genetic Vaccine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck Genetic Vaccine Product Offered
Table 94. Merck Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Merck Main Business
Table 96. Merck Latest Developments
Table 97. GSK Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. GSK Genetic Vaccine Product Offered
Table 99. GSK Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. GSK Main Business
Table 101. GSK Latest Developments
Table 102. Sanofi Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Genetic Vaccine Product Offered
Table 104. Sanofi Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Zoties Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 108. Zoties Genetic Vaccine Product Offered
Table 109. Zoties Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Zoties Main Business
Table 111. Zoties Latest Developments
Table 112. Elanco Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 113. Elanco Genetic Vaccine Product Offered
Table 114. Elanco Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Elanco Main Business
Table 116. Elanco Latest Developments
Table 117. Boehringer-Ingelheim Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 118. Boehringer-Ingelheim Genetic Vaccine Product Offered
Table 119. Boehringer-Ingelheim Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Boehringer-Ingelheim Main Business
Table 121. Boehringer-Ingelheim Latest Developments
Table 122. Indian Immunologicals Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 123. Indian Immunologicals Genetic Vaccine Product Offered
Table 124. Indian Immunologicals Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Indian Immunologicals Main Business
Table 126. Indian Immunologicals Latest Developments
Table 127. Plumbline Life Sciences Basic Information, Genetic Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 128. Plumbline Life Sciences Genetic Vaccine Product Offered
Table 129. Plumbline Life Sciences Genetic Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Plumbline Life Sciences Main Business
Table 131. Plumbline Life Sciences Latest Developments
List of Figures
Figure 1. Picture of Genetic Vaccine
Figure 2. Genetic Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetic Vaccine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Genetic Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Genetic Vaccine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Recombinant Protein Vaccine
Figure 10. Product Picture of Gene-Based Vaccine
Figure 11. Global Genetic Vaccine Sales Market Share by Type in 2021
Figure 12. Global Genetic Vaccine Revenue Market Share by Type (2017-2022)
Figure 13. Genetic Vaccine Consumed in Human
Figure 14. Global Genetic Vaccine Market: Human (2017-2022) & (K Units)
Figure 15. Genetic Vaccine Consumed in Animal
Figure 16. Global Genetic Vaccine Market: Animal (2017-2022) & (K Units)
Figure 17. Global Genetic Vaccine Sales Market Share by Application (2017-2022)
Figure 18. Global Genetic Vaccine Revenue Market Share by Application in 2021
Figure 19. Genetic Vaccine Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Genetic Vaccine Revenue Market Share by Company in 2021
Figure 21. Global Genetic Vaccine Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Genetic Vaccine Revenue Market Share by Geographic Region in 2021
Figure 23. Global Genetic Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Genetic Vaccine Revenue Market Share by Country/Region in 2021
Figure 25. Americas Genetic Vaccine Sales 2017-2022 (K Units)
Figure 26. Americas Genetic Vaccine Revenue 2017-2022 ($ Millions)
Figure 27. APAC Genetic Vaccine Sales 2017-2022 (K Units)
Figure 28. APAC Genetic Vaccine Revenue 2017-2022 ($ Millions)
Figure 29. Europe Genetic Vaccine Sales 2017-2022 (K Units)
Figure 30. Europe Genetic Vaccine Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Genetic Vaccine Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Genetic Vaccine Revenue 2017-2022 ($ Millions)
Figure 33. Americas Genetic Vaccine Sales Market Share by Country in 2021
Figure 34. Americas Genetic Vaccine Revenue Market Share by Country in 2021
Figure 35. United States Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Genetic Vaccine Sales Market Share by Region in 2021
Figure 40. APAC Genetic Vaccine Revenue Market Share by Regions in 2021
Figure 41. China Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Genetic Vaccine Sales Market Share by Country in 2021
Figure 48. Europe Genetic Vaccine Revenue Market Share by Country in 2021
Figure 49. Germany Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Genetic Vaccine Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Genetic Vaccine Revenue Market Share by Country in 2021
Figure 56. Egypt Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Genetic Vaccine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Genetic Vaccine in 2021
Figure 62. Manufacturing Process Analysis of Genetic Vaccine
Figure 63. Industry Chain Structure of Genetic Vaccine
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...